Dr. Hemant B. Tongaonkar serves as the Head of the Department of Surgical Oncology and Senior Director of Urologic & Gynecologic Oncosurgery at Nanavati Max Super Speciality Hospital in Mumbai. With over 36 years of experience, he has significantly contributed to the development of urologic and gynecologic oncology in India. Prior to his current role, Dr. Tongaonkar held prominent positions at esteemed institutions, including:

PD Hinduja National Hospital & Research Centre, Mumbai: Head of the Department of Surgical Oncology and Consultant Urologic & Gynecologic Oncologist (2012–2021).

Tata Memorial Hospital, Mumbai: Professor and Head of the Department of Surgical Oncology; Head of the Department of Urologic & Gynecologic Oncology (2002–2012); Consultant Urologic & Gynecologic Oncologist (1992–2012).

Dr. Tongaonkar completed his MBBS and MS in General Surgery from the University of Mumbai. He further honed his expertise through a three-year fellowship in Urologic & Gynecologic Oncology and a residency program in Surgical Oncology at Tata Memorial Hospital. His dedication to the field is evident through his active membership in numerous professional organizations, such as:

Urological Society of India

International Gynaecologic Cancer Society

Association of Gynaecologic Oncologists of India

Societe Internationale d’Urologie

Throughout his illustrious career, Dr. Tongaonkar has been honored with several awards, including:

Best Oncologist of The Year - West: Economic Times Healthcare Awards, 2023.

Urology Gold Medal: Urological Society of India West Zone for outstanding contributions to Urology in India, 2015.

Dr. Pinnamaneni Venkateswara Rao Gold Medal: Urological Society of India for significant contributions to Urologic Oncology in India, 2016.

Dr. Tongaonkar's clinical interests encompass personalized treatment approaches aimed at organ, function, fertility, and quality of life preservation, with a focus on reducing morbidity. He is a proponent of evidence-based multidisciplinary management to optimize patient outcomes. His expertise includes nephron-sparing surgery for kidney cancer, robot-assisted prostate cancer surgery, and ultraradical surgery for ovarian cancer, among others. In addition to his clinical practice, he has contributed to over 200 scientific publications and 17 book chapters, and has delivered numerous lectures and keynote addresses.